3F Therapeutics definition

3F Therapeutics shall have the meaning set forth in the preamble.

Examples of 3F Therapeutics in a sentence

  • Neither ATS Medical nor any such Related Person has acquired any 3F Therapeutics Securities in contemplation of the Merger, or otherwise as part of a plan of which the Merger is a part.

  • No income, gain or loss will be recognized by ATS Medical, Seabiscuit Acquisition Corp., or 3F Therapeutics as a result of the consummation of the Merger.

  • Prior to the Merger, ATS Medical will be in control of Seabiscuit, and following the Merger, ATS Medical will be in control of 3F Therapeutics, within the meaning of Section 368(c) of the Code.

  • The adoption of this Plan shall not affect any other compensation plans in effect for the Company or any Affiliate, nor preclude the Company or any Affiliate from establishing any other compensation plan.

  • To the extent that a 3F Therapeutics stockholder receives cash in lieu of a fractional share of ATS Medical common stock, the stockholder will be deemed to have received that fractional share in the Merger and then to have received the cash in redemption of that fractional share.

  • Following the Merger, 3F Therapeutics will hold at least 90 percent of the fair market value of 3F Therapeutics's net assets and at least 70 percent of the fair market value of 3F Therapeutics's gross assets and at least 90 percent of the fair market value of Seabiscuit's net assets and at least 70 percent of the fair market value of Seabiscuit's gross assets held immediately prior to the Effective Time.

  • The holding period of the shares of ATS Medical common stock received by a 3F Therapeutics stockholder in the Merger (other than shares of ATS Medical common stock taxable as imputed interest income) will include the holding period of the shares of 3F Therapeutics common stock surrendered in exchange therefore.

  • A portion of the ATS Medical common stock distributed to each 3F Therapeutics stockholder from the escrow or upon the achievement of a milestone (if any) will be taxable on receipt as imputed interest income under the Code.

  • This gain or loss generally will be long-term capital gain or loss if the holding period for those shares of 3F Therapeutics stock is more than one year as of the date of the Merger.

  • Within 30 days of the date hereof, Borrower shall cause each of 3F Therapeutics, Inc., a California corporation (“3F”), and ATS Acquisition Corp.

Related to 3F Therapeutics

  • Radiopharmaceutical means any drug that exhibits spontaneous disintegration of unstable nuclei with the emission of nuclear particles or photons and includes any non-radioactive reagent kit or radionuclide generator that is intended to be used in the preparation of any such substance, but does not include drugs such as carbon-containing compounds or potassium-containing salts that include trace quantities of naturally occurring radionuclides. The term also includes any biological product that is labeled with a radionuclide or intended solely to be labeled with a radionuclide.

  • IOSCO means the International Organisation of Securities Commissions.

  • AMS means the Federal Aviation Administration’s Acquisition Management System.

  • Raptor means all birds of the orders Falconiformes and Strigiformes, commonly called falcons,

  • Diagnostic Services means services provided for the purpose of determining the nature and cause of a condition, ill- ness, or injury.

  • Arena means an enclosed building:

  • Solutions means Products and Services provided under this “CPE Products & Services; Professional Services” Section.

  • Shire means Shire of Augusta Margaret River

  • Sage means The Sage Group plc or an Affiliate thereof.

  • DS Electric generation service that is provided at retail pursuant to the Applicable Legal Authorities under the Company’s retail electric tariffs and under any other agreements or arrangements between the Company and Customers, to any Customer that is not being served by an EGS. Default Allocation Assessment – shall have the meaning ascribed to it under the PJM Agreements. Delivery Period – The delivery period specified in an Appendix C Transaction Confirmation. Delivery Point – Means the applicable zone of the Company as designated by PJM. DS Customer(s) – Retail customers who are provided Default Service pursuant to the terms of this Agreement, the Applicable Legal Authorities and the Company’s retail tariffs.

  • Information Technologies means all information processing and communications-related hardware, Software, supplies, and consumable items that the Supplier is required to supply and install under the Contract.

  • Biotechnology means any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use.

  • Commercial Development Plan means the written commercialization plan attached as Appendix E.

  • First Commercial Sale means the first sale for use or consumption of any Licensed Product in a country after all required Regulatory Approvals for commercial sale of such Licensed Product have been obtained in such country.

  • CIMA means the Cayman Islands Monetary Authority;